Anebulo Pharmaceuticals, Inc. (ANEB) Financials
ANEB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 7.5 million | 1.0 million |
| 2023-09-30 | 9.0 million | 716560 |
| 2023-06-30 | 11.7 million | 1.1 million |
| 2023-03-31 | 14.4 million | 1.5 million |
ANEB Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -1.8 million | 219262 |
| 2023-09-30 | -2.7 million | 210797 |
| 2023-06-30 | -2.8 million | 223565 |
| 2023-03-31 | -2.2 million | 223637 |
ANEB Net Income
No data available :(
ANEB Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 6.6 million | - | - |
| 2023-09-30 | 8.5 million | - | - |
| 2023-06-30 | 11.2 million | - | - |
| 2023-03-31 | 14.2 million | - | - |
ANEB Shares Outstanding
ANEB Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | 1.1 million | 1.7 million | - |
| 2023-09-30 | - | 1.3 million | 1.3 million | - |
| 2023-06-30 | - | 1.4 million | 1.1 million | - |
| 2023-03-31 | - | 1.1 million | 1.8 million | - |
ANEB Cost of Revenue
No data available :(
ANEB
Price: $2.95
52 week price:
Earnings Per Share: -0.41 USD
P/E Ratio: -5.39
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 1471
Market Capitalization: 72.1 million